| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $32.3M | +16.3% |
| SG&A Expense | $23.9M | +51.6% |
| Operating Income | -$56.3M | -29.1% |
| Pre-tax Income | -$53.6M | -26.9% |
| Income Tax | $0 | — |
| Net Income | -$53.6M | -26.9% |
| EPS (Basic) | -$0.92 | -4.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $118.0M | +166.1% |
| Current Assets | $119.4M | +163.5% |
| Total Assets | $132.5M | +123.9% |
| Current Liabilities | $10.1M | +49.9% |
| Total Liabilities | $17.6M | +19.0% |
| Stockholders' Equity | $114.9M | +158.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.3M | -10.0% |
| Capital Expenditures | $125K | +3.3% |
| Investing Cash Flow | -$125K | -3.3% |
| Financing Cash Flow | $110.1M | +572.1% |
| Free Cash Flow | -$36.5M | -10.0% |